1,4-butanediol has been researched along with Drug Withdrawal Symptoms in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (63.64) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Bargel, S; Bonnet, A; Boukerma, AK; Chevallier, C; Dufayet, L; Evrard, M; Guillotin, S; Loeuillet, E; Paradis, C; Pouget, AM; Reynoard, J; Vaucel, JA | 1 |
| Gibson, KM; Goodwin, AK; Weerts, EM | 1 |
| Bosch, OG; Seifritz, E | 1 |
| Duketis, E; Holtmann, M; Maier, J; Poustka, F; Radeloff, D; Schirman, S; Wagner, A; Wöckel, L; Zepf, FD | 1 |
| Knudsen, K; Mégarbane, B; Schep, LJ; Slaughter, RJ; Vale, JA | 1 |
| Palmer, RB | 1 |
| Atzeri, S; Carai, MA; Colombo, G; Gessa, GL; Lobina, C; Maccioni, P; Maher, TJ; Orrù, A; Quang, LS | 1 |
| Gibson, KM; Snead, OC | 1 |
| Wax, PM; Wojtowicz, JM; Yarema, MC | 1 |
| Hall, BJ; McCutcheon, JR; Peacock, EA; Smith, SW; Spillane, J; Zvosec, DL | 1 |
| Aks, SE; Mycyk, MB; Wilemon, C | 1 |
7 review(s) available for 1,4-butanediol and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Gamma-hydroxybutyrate (GHB), 1,4-butanediol (1,4BD), and gamma-butyrolactone (GBL) intoxication: A state-of-the-art review.
Topics: 4-Butyrolactone; gamma-Aminobutyric Acid; Humans; Sodium Oxybate; Substance Withdrawal Syndrome | 2023 |
The behavioural profile of gamma-hydroxybutyrate, gamma-butyrolactone and 1,4-butanediol in humans.
Topics: 4-Butyrolactone; Animals; Butylene Glycols; Central Nervous System Depressants; Circadian Rhythm; Eating; Humans; Sexual Behavior; Social Behavior; Sodium Oxybate; Substance Withdrawal Syndrome | 2016 |
[Withdrawal syndrome after abuse of GHB (Gamma-Hydroxybutyrate) and its physiological precursors - its relevance for child and adolescent psychiatrists].
Topics: 4-Butyrolactone; Acute Disease; Adolescent; Anesthetics, Intravenous; Antipsychotic Agents; Benzodiazepines; Butylene Glycols; Child; Critical Care; Delusions; Diagnosis, Differential; Drug Interactions; Humans; Psychoses, Substance-Induced; Sodium Oxybate; Substance Withdrawal Syndrome; Substance-Related Disorders | 2009 |
The clinical toxicology of γ-hydroxybutyrate, γ-butyrolactone and 1,4-butanediol.
Topics: 4-Butyrolactone; Antidotes; Butylene Glycols; Charcoal; Humans; Sodium Oxybate; Substance Withdrawal Syndrome; Therapeutic Irrigation; Tissue Distribution | 2012 |
Gamma-butyrolactone and 1,4-butanediol: abused analogues of gamma-hydroxybutyrate.
Topics: 4-Butyrolactone; Body Temperature Regulation; Butylene Glycols; GABA Modulators; Humans; Illicit Drugs; Seizures; Sodium Oxybate; Substance Withdrawal Syndrome; Substance-Related Disorders | 2004 |
Gamma-hydroxybutyric acid.
Topics: 4-Butyrolactone; Animals; Butylene Glycols; Humans; Hydroxybutyrates; Receptors, Cell Surface; Receptors, Dopamine; Receptors, GABA; Substance Withdrawal Syndrome; Substance-Related Disorders | 2005 |
Withdrawal from gamma-hydroxybutyrate, 1,4-butanediol and gamma-butyrolactone: a case report and systematic review.
Topics: 4-Butyrolactone; Adult; Butylene Glycols; Humans; Illicit Drugs; Male; Rhabdomyolysis; Seizures; Sodium Oxybate; Substance Withdrawal Syndrome | 2008 |
4 other study(ies) available for 1,4-butanediol and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
Physical dependence on gamma-hydroxybutrate (GHB) prodrug 1,4-butanediol (1,4-BD): time course and severity of withdrawal in baboons.
Topics: Animals; Butylene Glycols; Conditioning, Operant; Infusions, Parenteral; Male; Papio anubis; Prodrugs; Severity of Illness Index; Sodium Oxybate; Substance Withdrawal Syndrome; Substance-Related Disorders; Time Factors | 2013 |
Withdrawal syndrome from gamma-hydroxybutyric acid (GHB) and 1,4-butanediol (1,4-BD) in Sardinian alcohol-preferring rats.
Topics: Animals; Butylene Glycols; Disease Models, Animal; GABA-B Receptor Antagonists; Hydroxybutyrates; Male; Morpholines; Rats; Rats, Inbred Strains; Substance Withdrawal Syndrome; Substance-Related Disorders | 2005 |
Adverse events, including death, associated with the use of 1,4-butanediol.
Topics: Adult; Butylene Glycols; Dietary Supplements; Fatal Outcome; Female; Humans; Male; Psychomotor Agitation; Pulmonary Edema; Sodium Oxybate; Substance Withdrawal Syndrome; Substance-Related Disorders; Unconsciousness; Vomiting | 2001 |
Two cases of withdrawal from 1,4-Butanediol use.
Topics: Adult; Butylene Glycols; Emergencies; Female; Humans; Male; Sodium Oxybate; Substance Withdrawal Syndrome | 2001 |